Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacter
Urinary tract infections (UTIs) are one of the most common pathologies encountered in general practice. However, with increasing bacterial resistance to antibiotics, their treatment is becoming increasingly complex. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) pose a particular challenge due t
| Condition(s) | Urinary Tract Infections |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Urinary tract infections (UTIs) are one of the most common pathologies encountered in general practice. However, with increasing bacterial resistance to antibiotics, their treatment is becoming increasingly complex. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) pose a particular challenge due to their increased resistance to many commonly used antibiotics. The aim of this thesis is to study the management of such infections by general practitioners in Bas-Rhin and to suggest possible avenues for improvement. |
| Who can participate | Inclusion Criteria: * Adult (≥18 years old) * Subject with an Enterobacteriaceae urinary tract infection treated in a primary care setting for urinary tract infection between June 1, 2024 and December 31, 2024 * Subject not objecting, after being informed, to the reuse of their data for the purposes of this research. * The subject's primary care physician agreeing to participate in the study Exclusion Criteria: * Subject and/or their primary care physician having expressed their opposition to participating in the study * Subject under legal protection * Subject under guardianship or curatorship |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | University Hospital, Strasbourg, France |
| Locations | Strasbourg, France |
| Start date | 2024-10-24 |
| NCT ID | NCT06910878 |
| Official listing | https://clinicaltrials.gov/study/NCT06910878 |